Variant report
Variant | esv3489411 |
---|---|
Chromosome Location | chr4:142865824-142926421 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:142881011..142883587-chr4:142896903..142898458,2 | K562 | blood: | |
2 | chr4:142881011..142883587-chr4:142896903..142898458,2 | K562 | blood: | |
3 | chr4:142879245..142882924-chr4:142883253..142886300,3 | K562 | blood: | |
4 | chr4:142879245..142882924-chr4:142883253..142886300,3 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs574708364 | chr4:142879059-142879060 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs543122945 | chr4:142879068-142879069 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs532901198 | chr4:142879081-142879082 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs561401428 | chr4:142879134-142879135 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs576494349 | chr4:142879141-142879142 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs543498607 | chr4:142879211-142879212 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs183769124 | chr4:142879381-142879382 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs565284799 | chr4:142879389-142879390 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs367723922 | chr4:142879424-142879425 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs532653367 | chr4:142879435-142879436 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs149774721 | chr4:142879464-142879465 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs1500846 | chr4:142879478-142879479 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs530256843 | chr4:142879489-142879490 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs145731019 | chr4:142879511-142879512 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs148927923 | chr4:142879557-142879558 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs145477586 | chr4:142879572-142879573 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs375945263 | chr4:142886223-142886224 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs572534833 | chr4:142886272-142886273 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs148052158 | chr4:142886315-142886316 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs560779485 | chr4:142886326-142886327 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs528160666 | chr4:142886340-142886341 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs189977560 | chr4:142886346-142886347 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs576409920 | chr4:142886375-142886376 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs201996967 | chr4:142886444-142886445 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs116836072 | chr4:142886485-142886486 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs6849970 | chr4:142886512-142886513 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
27 | rs180820183 | chr4:142886538-142886539 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs79860924 | chr4:142886553-142886554 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs559529168 | chr4:142886565-142886566 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs529705943 | chr4:142886594-142886595 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs115952904 | chr4:142886626-142886627 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs569535956 | chr4:142886631-142886632 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs564662174 | chr4:142886677-142886678 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs144565508 | chr4:142886698-142886699 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs1500832 | chr4:142886724-142886725 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs62327922 | chr4:142886749-142886750 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs368107487 | chr4:142886823-142886824 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs4626288 | chr4:142886866-142886867 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs138597729 | chr4:142886903-142886904 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs568285948 | chr4:142886907-142886908 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs186280919 | chr4:142886914-142886915 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs555078611 | chr4:142886936-142886937 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs576346282 | chr4:142886938-142886939 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs543845158 | chr4:142886956-142886957 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs141683129 | chr4:142886957-142886958 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs548063649 | chr4:142886970-142886971 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs566685959 | chr4:142886980-142886981 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs551041412 | chr4:142886992-142886993 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs559500454 | chr4:142886994-142886995 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs566365589 | chr4:142887005-142887006 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 16272173 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Mental retardation | 17901693 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Obesity | 20622171 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Breast cancer | 22048815 | CNVD |
Autism | 22241247 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:142879000-142879600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
2 | chr4:142886200-142887200 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
3 | chr4:142887000-142887400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr4:142887200-142887600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr4:142894000-142894400 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr4:142898200-142899000 | Enhancers | HSMMtube | muscle |
7 | chr4:142919200-142919600 | ZNF genes & repeats | Osteobl | bone |
8 | chr4:142920000-142921000 | Enhancers | K562 | blood |
9 | chr4:142920600-142921200 | Enhancers | Fetal Heart | heart |
10 | chr4:142921000-142922000 | Weak transcription | K562 | blood |
11 | chr4:142922000-142922200 | Enhancers | K562 | blood |